Effect of dapagliflozin on cardiovascular outcomes in patients with type 2 diabetes according to baseline renal function and albuminuria status: Insights from DECLARE-TIMI 58

Citation
Zelniker TA, Raz I, Mosenzon O, et al. Eur Heart J 2019;40(Suppl 1):ehz747.0052.